Production (Stage)
Innovation1 Biotech Inc.
IVBT
$0.005
$0.00482,400.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Net Income | 51.99% | 59.60% | 88.04% | 81.43% | 66.08% |
| Total Depreciation and Amortization | 0.00% | -99.42% | -99.96% | -99.97% | -99.97% |
| Total Amortization of Deferred Charges | 547.96% | 3,392.59% | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -89.97% | 49,800.00% | -- |
| Change in Net Operating Assets | -84.67% | -97.43% | 264.15% | -214.77% | 113.03% |
| Cash from Operations | 28.98% | 22.69% | 94.39% | 71.92% | 87.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00% | 113.80% | -- | 105.34% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 113.80% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.84% | 69.70% | 94.39% | 103.59% | 102.54% |